Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 253,699 shares at $95.07 ($25.4M) on 2019-08-14, disclosed to the SEC on 2019-08-16.
Open-market sale of $25.4M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.07 | 4,715 | $448K | 1.8% |
| 2 | $95.91 | 6,107 | $586K | 2.3% |
| 3 | $97.20 | 3,921 | $381K | 1.5% |
| 4 | $98.23 | 13,704 | $1.3M | 5.3% |
| 5 | $99.12 | 20,321 | $2.0M | 7.9% |
| 6 | $100.67 | 12,300 |
| $1.2M |
| 4.9% |
| 7 | $101.42 | 200 | $20K | 0.1% |
| 8 | $97.80 | 6,404 | $626K | 2.5% |
| 9 | $98.74 | 19,040 | $1.9M | 7.4% |
| 10 | $99.10 | 892 | $88K | 0.3% |
| 11 | $100.40 | 22,127 | $2.2M | 8.7% |
| 12 | $101.18 | 133,534 | $13.5M | 53.1% |
| 13 | $101.66 | 10,434 | $1.1M | 4.2% |
| Total | $100.21 avg | 253,699 | $25.4M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |